Peer-reviewedCC BYJournal of clinical medicine
Scrambler Therapy for Chronic Neuropathic Pain: Why the Evidence Base Has Not Converged, and What Standardization Would Require
- 1Eco Samsung Orthopedic Clinic, 25 Sebyeongnam-ro, Jeonju-si 54819, Jeollabuk-do, Republic of Korea
Related
- How Many Factors Underlie the WAIS-5? Evidence From the Australian and New Zealand Standardization Sample.
- Radiation Segmentectomy for Primary and Metastatic Liver Tumors: Current Evidence, Tumor-Specific Dosimetric Rationale, and the Need for Standardization
- Evaluating Acupuncture for Chemotherapy-Induced Peripheral Neuropathic Pain: A Narrative Review of Clinical Evidence and Mechanistic Perspectives
- Therapy-Induced Senescence in Cancer Treatment Resistance: Mechanisms, Evidence, and Translational Opportunities
- Adjuvant and Perioperative Systemic Therapy for Resectable Hepatocellular Carcinoma: Evidence, Biological Rationale, and Trial Design
BibTeX
@article{cho2026scrambler,
title = {{Scrambler Therapy for Chronic Neuropathic Pain: Why the Evidence Base Has Not Converged, and What Standardization Would Require}},
author = {Hyungin Cho and Heeyeon Yoon and JinHan Lee and Junhwan Jung and Ingyu Lee},
journal = {Journal of clinical medicine},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13666451},
note = {CC BY},
}
RIS
TY - JOUR
TI - Scrambler Therapy for Chronic Neuropathic Pain: Why the Evidence Base Has Not Converged, and What Standardization Would Require
AU - Hyungin Cho
AU - Heeyeon Yoon
AU - JinHan Lee
AU - Junhwan Jung
AU - Ingyu Lee
PY - 2026
DA - 2026/09/26
JO - Journal of clinical medicine
UR - https://europepmc.org/article/PMC/PMC13666451
SN - 2077-0383
ER -